Back to URGN
SILVERARC CAPITAL MANAGEMENT, LLC → URGN
SILVERARC CAPITAL MANAGEMENT, LLC URGN Position History
UroGen Pharma Ltd. • Healthcare
Quarters held
4
Latest value
$46.7M
Q3 2026
Peak value
$47.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $40.7M |
| Q1 2026 | $27M |
| Q2 2026 | $47.9M |
| Q3 2026 | $46.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $46.7M | 1.15M | — | — |
| Q2 2026 | $47.9M | 1.30M | — | — |
| Q1 2026 | $27M | 1.50M | — | — |
| Q4 2025 | $40.7M | 1.74M | — | — |
Other funds holding URGN
$184.6M
$167.2M
$106.4M
$93.6M
$91.7M